| MIR6723 | microRNA 6723 | 1
| 1.118 |
| LOC101928626 | NA | NA
| 1.081 |
| AFF1 | AF4/FMR2 family, member 1 | 4q21.3
| 0.963 |
| RNA28S5 | RNA, 28S ribosomal 5 | 22p12
| 0.741 |
| RNA5-8S5 | RNA, 5.8S ribosomal 5 | 22p12
| 0.703 |
| RNA18S5 | RNA, 18S ribosomal 5 | 22p12
| 0.625 |
| MIR3687-1 | microRNA 3687-1 | 21
| 0.606 |
| MIR3687-2 | microRNA 3687-2 | 21
| 0.606 |
| SRI | sorcin | 7q21.1
| 0.605 |
| MIR3648-1 | microRNA 3648-1 | 21
| 0.597 |
| MIR3648-2 | microRNA 3648-2 | 21
| 0.597 |
| MIR4461 | microRNA 4461 | 5
| 0.583 |
| TTLL6 | tubulin tyrosine ligase-like family member 6 | 17q21.32
| 0.57 |
| CDC42SE2 | CDC42 small effector 2 | 5q31.1
| 0.568 |
| MTRNR2L1 | MT-RNR2-like 1 | 17p11.2
| 0.565 |
| MIR6724-1 | microRNA 6724-1 | 21
| 0.526 |
| MIR6724-2 | microRNA 6724-2 | 21
| 0.526 |
| MIR6724-3 | microRNA 6724-3 | 21
| 0.526 |
| MIR6724-4 | microRNA 6724-4 | 21
| 0.526 |
| MIR5707 | microRNA 5707 | 7
| 0.524 |
| MIR4477A | microRNA 4477a | 9
| 0.514 |
| MIR4477B | microRNA 4477b | 9
| 0.512 |
| COL23A1 | collagen, type XXIII, alpha 1 | 5q35.3
| 0.498 |
| NHSL1 | NHS-like 1 | 6q23.3
| 0.498 |
| SOAT1 | sterol O-acyltransferase 1 | 1q25
| 0.489 |
| TMEM62 | transmembrane protein 62 | 15q15.2
| 0.485 |
| MIR663A | microRNA 663a | 20p11.1
| 0.465 |
| PRLR | prolactin receptor | 5p14-p13
| 0.451 |
| PTPRN2 | protein tyrosine phosphatase, receptor type, N polypeptide 2 | 7q36
| 0.45 |
| LOC102723885 | NA | NA
| 0.4 |
| ARHGEF18 | Rho/Rac guanine nucleotide exchange factor (GEF) 18 | 19p13.3
| 0.389 |
| LOC100507412 | NA | NA
| 0.387 |
| CACNA1C-IT3 | CACNA1C intronic transcript 3 | 12p13.33
| 0.349 |
| ZNF707 | zinc finger protein 707 | 8q24.3
| 0.335 |
| SMIM14 | small integral membrane protein 14 | 4p14
| 0.321 |
| TSPAN8 | tetraspanin 8 | 12q14.1-q21.1
| 0.287 |
| ZNF623 | zinc finger protein 623 | 8q24.3
| 0.275 |
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 15q13
| 0.253 |
| PCBD2 | pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 | 5q31.1
| 0.252 |
| IDH2 | isocitrate dehydrogenase 2 (NADP+), mitochondrial | 15q26.1
| 0.249 |
| LOC100128573 | NA | NA
| 0.246 |
| MAPK8 | mitogen-activated protein kinase 8 | 10q11
| 0.236 |
| LOC101929512 | NA | NA
| 0.231 |
| BREA2 | NA | NA
| 0.202 |
| PSMD14 | proteasome 26S subunit, non-ATPase 14 | 2q14.3
| 0.186 |
| TBC1D16 | TBC1 domain family, member 16 | 17q25.3
| 0.184 |
| CCDC40 | coiled-coil domain containing 40 | 17q25.3
| 0.178 |
| CACNA1C-AS4 | CACNA1C antisense RNA 4 | 12p13.33
| 0.166 |
| LOC100996579 | NA | NA
| 0.156 |
| LOC642236 | NA | NA
| 0.15 |
| CALCOCO2 | calcium binding and coiled-coil domain 2 | 17q21.32
| 0.149 |
| SNORA36C | small nucleolar RNA, H/ACA box 36C | 2p14
| 0.142 |
| OR4F29 | olfactory receptor, family 4, subfamily F, member 29 | 1p36.33
| 0.137 |
| OR4F3 | olfactory receptor, family 4, subfamily F, member 3 | 5q35.3
| 0.137 |
| OR4F16 | olfactory receptor, family 4, subfamily F, member 16 | 1p36.33
| 0.137 |
| PEX11G | peroxisomal biogenesis factor 11 gamma | 19p13.2
| 0.131 |
| CCDC166 | coiled-coil domain containing 166 | 8q24.3
| 0.13 |
| CATSPER3 | cation channel, sperm associated 3 | 5q31.2
| 0.118 |
| CLK4 | CDC-like kinase 4 | 5q35
| 0.116 |
| SLC19A3 | solute carrier family 19 (thiamine transporter), member 3 | 2q37
| 0.103 |
| NFU1 | NFU1 iron-sulfur cluster scaffold | 2p15-p13
| 0.095 |
| MAPK15 | mitogen-activated protein kinase 15 | 8q24.3
| 0.093 |
| C19orf45 | chromosome 19 open reading frame 45 | 19p13.2
| 0.093 |
| CCL20 | chemokine (C-C motif) ligand 20 | 2q36.3
| 0.077 |
| TSTA3 | tissue specific transplantation antigen P35B | 8q24.3
| 0.076 |
| TXNDC15 | thioredoxin domain containing 15 | 5q31.1
| 0.072 |
| CCNDBP1 | cyclin D-type binding-protein 1 | 15q14-q15
| 0.061 |
| CHEK2P2 | checkpoint kinase 2 pseudogene 2 | 15q11.1
| 0.059 |
| ABL2 | ABL proto-oncogene 2, non-receptor tyrosine kinase | 1q25.2
| 0.058 |
| PYCRL | pyrroline-5-carboxylate reductase-like | 8q24.3
| 0.055 |
| SEMA4B | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4B | 15q25
| 0.055 |
| LOC100506746 | NA | NA
| 0.054 |
| MIR595 | microRNA 595 | 7q36.3
| 0.05 |
| FRG2B | FSHD region gene 2 family, member B | 10q26.3
| 0.05 |
| MIR4664 | microRNA 4664 | 8
| 0.048 |
| CCNG1 | cyclin G1 | 5q32-q34
| 0.047 |
| FAM83H | family with sequence similarity 83, member H | 8q24.3
| 0.047 |
| FAM83H-AS1 | FAM83H antisense RNA 1 (head to head) | 8q24.3
| 0.046 |
| DEFB115 | defensin, beta 115 | 20q11.21
| 0.045 |
| ZNF358 | zinc finger protein 358 | 19p13.2
| 0.044 |
| HOXB13 | homeobox B13 | 17q21.32
| 0.041 |
| MIR3145 | microRNA 3145 | 6
| 0.038 |
| MIR3185 | microRNA 3185 | 17
| 0.035 |
| TIGD5 | tigger transposable element derived 5 | 8q24.3
| 0.034 |
| MCOLN1 | mucolipin 1 | 19p13.2
| 0.034 |
| EEF1D | eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) | 8q24
| 0.034 |
| PRAC2 | prostate cancer susceptibility candidate 2 | 17q21.3
| 0.034 |
| PRAC1 | prostate cancer susceptibility candidate 1 | 17q21
| 0.032 |
| UBE2K | ubiquitin-conjugating enzyme E2K | 4p14
| 0.03 |
| CD200 | CD200 molecule | 3q13.2
| 0.03 |
| AXDND1 | axonemal dynein light chain domain containing 1 | 1q25.2
| 0.027 |
| LOC101928766 | NA | NA
| 0.025 |
| STEAP4 | STEAP family member 4 | 7q21.13
| 0.025 |
| C5orf24 | chromosome 5 open reading frame 24 | 5q31.1
| 0.024 |
| LINC00273 | long intergenic non-protein coding RNA 273 | 16p11.2
| 0.024 |
| PNPLA6 | patatin-like phospholipase domain containing 6 | 19p13.2
| 0.022 |
| NUDCD2 | NudC domain containing 2 | 5q34
| 0.019 |
| LOC101928738 | NA | NA
| 0.019 |
| HMMR | hyaluronan-mediated motility receptor (RHAMM) | 5q34
| 0.019 |
| BAGE | B melanoma antigen | 21p11.1 not on reference assembly
| 0.018 |
| BAGE4 | B melanoma antigen family, member 4 | 21p11.1
| 0.018 |
| BAGE3 | B melanoma antigen family, member 3 | 21p11.2
| 0.018 |
| BAGE2 | B melanoma antigen family, member 2 | 21p11.2
| 0.018 |
| BAGE5 | B melanoma antigen family, member 5 | 13cen
| 0.018 |
| LINC01523 | long intergenic non-protein coding RNA 1523 | 20q13.13
| 0.018 |
| BTLA | B and T lymphocyte associated | 3q13.2
| 0.016 |
| NAPRT | nicotinate phosphoribosyltransferase | 8q24.3
| 0.016 |
| MIR1268B | microRNA 1268b | 17
| 0.015 |
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 7q31.2
| 0.015 |
| EPB42 | erythrocyte membrane protein band 4.2 | 15q15-q21
| 0.015 |
| LYRM7 | LYR motif containing 7 | 5q31.1
| 0.014 |
| UGDH-AS1 | UGDH antisense RNA 1 | 4p14
| 0.014 |
| LINC01522 | long intergenic non-protein coding RNA 1522 | 20q13.13
| 0.013 |
| UGDH | UDP-glucose 6-dehydrogenase | 4p14
| 0.013 |
| GAA | glucosidase, alpha; acid | 17q25.2-q25.3
| 0.013 |
| LOC100133331 | NA | NA
| 0.013 |
| GFPT1 | glutamine--fructose-6-phosphate transaminase 1 | 2p13
| 0.013 |
| MROH6 | maestro heat-like repeat family member 6 | 8q24.3
| 0.013 |
| ATP5G1 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) | 17q21.32
| 0.013 |
| ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain | 1p31
| 0 |
| AGL | amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | 1p21
| 0 |
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 1q42.2
| 0 |
| AMPD1 | adenosine monophosphate deaminase 1 | 1p13
| 0 |
| C8B | complement component 8, beta polypeptide | 1p32.2
| 0 |
| CACNA1S | calcium channel, voltage-dependent, L type, alpha 1S subunit | 1q32
| 0 |
| LYST | lysosomal trafficking regulator | 1q42.1-q42.2
| 0 |
| CLCNKB | chloride channel, voltage-sensitive Kb | 1p36
| 0 |
| CPT2 | carnitine palmitoyltransferase 2 | 1p32.3
| 0 |
| DPYD | dihydropyrimidine dehydrogenase | 1p22
| 0 |
| EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | 1q42.1
| 0 |
| F5 | coagulation factor V (proaccelerin, labile factor) | 1q23
| 0 |
| FH | fumarate hydratase | 1q42.1
| 0 |
| FUCA1 | fucosidase, alpha-L- 1, tissue | 1p34
| 0 |
| GBA | glucosidase, beta, acid | 1q22
| 0 |
| CFH | complement factor H | 1q32
| 0 |
| HMGCL | 3-hydroxymethyl-3-methylglutaryl-CoA lyase | 1p36.1-p35
| 0 |
| HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 1p12
| 0 |
| LAMB3 | laminin, beta 3 | 1q32
| 0 |
| MTR | 5-methyltetrahydrofolate-homocysteine methyltransferase | 1q43
| 0 |
| MYOC | myocilin, trabecular meshwork inducible glucocorticoid response | 1q23-q24
| 0 |
| PKLR | pyruvate kinase, liver and RBC | 1q22
| 0 |
| PKP1 | plakophilin 1 | 1q32
| 0 |
| PLA2G2A | phospholipase A2, group IIA (platelets, synovial fluid) | 1p35
| 0 |
| PLOD1 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 | 1p36.22
| 0 |
| PPOX | protoporphyrinogen oxidase | 1q22
| 0 |
| PPT1 | palmitoyl-protein thioesterase 1 | 1p32
| 0 |
| RPE65 | retinal pigment epithelium-specific protein 65kDa | 1p31
| 0 |
| ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | 1p22
| 0 |
| TNNT2 | troponin T type 2 (cardiac) | 1q32
| 0 |
| UROD | uroporphyrinogen decarboxylase | 1p34
| 0 |
| CTSK | cathepsin K | 1q21
| 0 |
| GALE | UDP-galactose-4-epimerase | 1p36-p35
| 0 |
| LOR | loricrin | 1q21
| 0 |
| NCF2 | neutrophil cytosolic factor 2 | 1q25
| 0 |
| PAFAH2 | platelet-activating factor acetylhydrolase 2, 40kDa | 1p34.3
| 0 |
| PSEN2 | presenilin 2 | 1q42.13
| 0 |
| RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 1q21
| 0 |
| SELE | selectin E | 1q24.2
| 0 |
| ALPL | alkaline phosphatase, liver/bone/kidney | 1p36.12
| 0 |
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 1q25.1
| 0 |
| C1QB | complement component 1, q subcomponent, B chain | 1p36.3-p34.1
| 0 |
| MPZ | myelin protein zero | 1q22
| 0 |
| REN | renin | 1q32
| 0 |
| TSHB | thyroid stimulating hormone, beta | 1p13
| 0 |
| CD53 | CD53 molecule | 1p13
| 0 |
| GSTM1 | glutathione S-transferase mu 1 | 1p13.3
| 0 |
| C8A | complement component 8, alpha polypeptide | 1p32.2
| 0 |
| IL6R | interleukin 6 receptor | 1q21
| 0 |
| FCGR1A | Fc fragment of IgG, high affinity Ia, receptor (CD64) | 1q21.2-q21.3
| 0 |
| CRP | C-reactive protein, pentraxin-related | 1q23.2
| 0 |
| FCGR3A | Fc fragment of IgG, low affinity IIIa, receptor (CD16a) | 1q23
| 0 |
| FCGR3B | Fc fragment of IgG, low affinity IIIb, receptor (CD16b) | 1q23
| 0 |
| IL10 | interleukin 10 | 1q31-q32
| 0 |
| CR1 | complement component (3b/4b) receptor 1 (Knops blood group) | 1q32
| 0 |
| CD55 | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 1q32
| 0 |
| FASLG | Fas ligand (TNF superfamily, member 6) | 1q23
| 0 |
| SELL | selectin L | 1q24.2
| 0 |
| ADORA1 | adenosine A1 receptor | 1q32.1
| 0 |
| ADORA3 | adenosine A3 receptor | 1p13.2
| 0 |
| ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 | 1q24.1
| 0 |
| AMY2A | amylase, alpha 2A (pancreatic) | 1p21.1
| 0 |
| ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | 1p13
| 0 |
| ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 1q23.2
| 0 |
| AVPR1B | arginine vasopressin receptor 1B | 1q32
| 0 |
| C4BPA | complement component 4 binding protein, alpha | 1q32
| 0 |
| C4BPB | complement component 4 binding protein, beta | 1q32
| 0 |
| CACNA1E | calcium channel, voltage-dependent, R type, alpha 1E subunit | 1q25.3
| 0 |
| CD247 | CD247 molecule | 1q24.2
| 0 |
| CHRM3 | cholinergic receptor, muscarinic 3 | 1q43
| 0 |
| CHRNB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) | 1q21.3
| 0 |
| CSF1 | colony stimulating factor 1 (macrophage) | 1p13.3
| 0 |
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 1p35-p34.3
| 0 |
| CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | 1p31.3-p31.2
| 0 |
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 1p33
| 0 |
| CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 1p33
| 0 |
| DIO1 | deiodinase, iodothyronine, type I | 1p33-p32
| 0 |
| GABRD | gamma-aminobutyric acid (GABA) A receptor, delta | 1p36.3
| 0 |
| GRIK3 | glutamate receptor, ionotropic, kainate 3 | 1p34.3
| 0 |
| GSTM2 | glutathione S-transferase mu 2 (muscle) | 1p13.3
| 0 |
| GSTM3 | glutathione S-transferase mu 3 (brain) | 1p13.3
| 0 |